Table 3.
HR | [95% | CI#] | p value | |
---|---|---|---|---|
Socio demographic | ||||
Caucasian race | 2.30 | 1.05 | 5.02 | 0.036 |
Age (years) | 0.99 | 0.95 | 1.03 | 0.684 |
Later period | 1.12 | 0.50 | 2.56 | 0.778 |
Residence in NE or W regions | 1.62 | 1.09 | 2.40 | 0.015 |
Baseline status | ||||
CD4 count (100 cell/μl) | 0.49 | 0.33 | 0.72 | <0.001 |
Log HIV-1 VL | 0.94 | 0.51 | 1.74 | 0.851 |
KSHV seropositivity | 9.52 | 3.58 | 25.30 | <0.001 |
Antiherpesvirus drugs | ||||
Anti HSV | 2.19 | 1.00 | 4.81 | 0.051 |
Anti CMV | 3.63 | 0.46 | 29.77 | 0.221 |
cART | ||||
Assigned PI | 1.51 | 0.71 | 3.21 | 0.278 |
CD4 response | ||||
No CD4count increase | Ref. | |||
Any CD4 count increase | 1.23 | 0.16 | 9.24 | 0.841 |
HR, hazard ratio
CI, confidence interval